SplitJun 4, 2026, 08:57 AM
Alterity Therapeutics Completes 1-for-50 Share Consolidation
AI Summary
Alterity Therapeutics has completed a 1-for-50 share capital consolidation, effective after shareholder approval received on May 29, 2026. The company's securities will trade under the temporary ASX code "ATHDA" from June 3 to June 11, 2026, on a post-consolidation and deferred settlement basis. Normal trading under the ASX code "ATH" will resume on June 12, 2026, with the number of shares held by shareholders reduced and the share price adjusted accordingly.
Key Highlights
- Share capital consolidated on a 1 for 50 basis.
- Shareholder approval received at the EGM on May 29, 2026.
- Trading under temporary ASX code "ATHDA" from June 3 to June 11, 2026.
- Record date for the consolidation is June 4, 2026.
- Normal trading under ASX code "ATH" commences June 12, 2026.
- Fractional entitlements rounded up to the nearest whole number.
- Company's share price has adjusted accordingly.
Price Impact
More from ATHE